William V. Walsh, MD
Research Focus - Multi-modality Treatment of Lung and Head and Neck Cancers
- Use of chemotherapy and novel immune-based treatments for lung and head and neck cancer
- Use of comprehensive DNA/RNA analysis and molecular targeted therapies to treat lung and head and neck cancers
Representative Publication
Li T, Piperdi B, Walsh WV, et al. Randomized phase 2 trial of pharmacodynamic separation of pemetrexed and intercalated erlotinib versus pemetrexed alone for advanced non-squamous non-small cell lung cancer. Clin Lung Cancer. 2017;18(1):60-67.